Antacid therapy for gastroesophageal reflux in preterm infants: a systematic review

Background: Gastro-oesophageal reflux is prevalent in preterm infants. Despite widespread use in clinical practice, there is still much controversy over the efficacy and safety of drug interventions, particularly antacid therapy. Objective: To systematically review the effects of antacid therapy on...

Full description

Bibliographic Details
Main Authors: Dermyshi, Elda, Mackie, Charley, Kigozi, Phoebe, Schoonakker, Bernard, Dorling, Jon
Format: Article
Published: BMJ Publishing Group 2018
Subjects:
Online Access:https://eprints.nottingham.ac.uk/52333/
_version_ 1848798702974533632
author Dermyshi, Elda
Mackie, Charley
Kigozi, Phoebe
Schoonakker, Bernard
Dorling, Jon
author_facet Dermyshi, Elda
Mackie, Charley
Kigozi, Phoebe
Schoonakker, Bernard
Dorling, Jon
author_sort Dermyshi, Elda
building Nottingham Research Data Repository
collection Online Access
description Background: Gastro-oesophageal reflux is prevalent in preterm infants. Despite widespread use in clinical practice, there is still much controversy over the efficacy and safety of drug interventions, particularly antacid therapy. Objective: To systematically review the effects of antacid therapy on preterm infants with symptoms of gastro-oesophageal reflux, and to assess the safety of these interventions. Methods: We carried out an electronic search of the Cochrane central register of controlled trials (CENTRAL, The Cochrane Library), MEDLINE (1966–present), EMBASE (1980–present) and CINAHL (1982–present) as well as other online sources. Participants were preterm infants (<37 weeks gestation) with gastro-oesophageal reflux disease who were receiving care on a neonatal unit. We assessed the effects of histamine-2 receptor antagonists, proton pump inhibitors and alginates against placebo, primarily to see if they reduced the symptoms of reflux. Results: Six studies were included in this review. Meta-analysis could not be carried out due to a lack of studies assessing the same intervention with the same outcomes. Omeprazole therapy significantly reduced the oesophageal acid exposure percentage time with pH<4 (p<0.01) and sodium alginate significantly decreased gastro-oesophageal reflux episodes (p=0.024). Metoclopramide and ranitidine showed a significant increase in gastro-oesophageal reflux disease symptoms versus placebo (p<0.04). No significant results were found for the use of esomeprazole or lansoprazole versus placebo. Conclusions: There is insufficient evidence available to conclude whether antacid therapy is effective or safe when treating gastro-oesophageal reflux disease in preterm infants. Further research is needed into this topic and caution should be taken when administering antacids to preterm infants.
first_indexed 2025-11-14T20:23:59Z
format Article
id nottingham-52333
institution University of Nottingham Malaysia Campus
institution_category Local University
last_indexed 2025-11-14T20:23:59Z
publishDate 2018
publisher BMJ Publishing Group
recordtype eprints
repository_type Digital Repository
spelling nottingham-523332024-08-15T15:30:37Z https://eprints.nottingham.ac.uk/52333/ Antacid therapy for gastroesophageal reflux in preterm infants: a systematic review Dermyshi, Elda Mackie, Charley Kigozi, Phoebe Schoonakker, Bernard Dorling, Jon Background: Gastro-oesophageal reflux is prevalent in preterm infants. Despite widespread use in clinical practice, there is still much controversy over the efficacy and safety of drug interventions, particularly antacid therapy. Objective: To systematically review the effects of antacid therapy on preterm infants with symptoms of gastro-oesophageal reflux, and to assess the safety of these interventions. Methods: We carried out an electronic search of the Cochrane central register of controlled trials (CENTRAL, The Cochrane Library), MEDLINE (1966–present), EMBASE (1980–present) and CINAHL (1982–present) as well as other online sources. Participants were preterm infants (<37 weeks gestation) with gastro-oesophageal reflux disease who were receiving care on a neonatal unit. We assessed the effects of histamine-2 receptor antagonists, proton pump inhibitors and alginates against placebo, primarily to see if they reduced the symptoms of reflux. Results: Six studies were included in this review. Meta-analysis could not be carried out due to a lack of studies assessing the same intervention with the same outcomes. Omeprazole therapy significantly reduced the oesophageal acid exposure percentage time with pH<4 (p<0.01) and sodium alginate significantly decreased gastro-oesophageal reflux episodes (p=0.024). Metoclopramide and ranitidine showed a significant increase in gastro-oesophageal reflux disease symptoms versus placebo (p<0.04). No significant results were found for the use of esomeprazole or lansoprazole versus placebo. Conclusions: There is insufficient evidence available to conclude whether antacid therapy is effective or safe when treating gastro-oesophageal reflux disease in preterm infants. Further research is needed into this topic and caution should be taken when administering antacids to preterm infants. BMJ Publishing Group 2018-07-09 Article PeerReviewed Dermyshi, Elda, Mackie, Charley, Kigozi, Phoebe, Schoonakker, Bernard and Dorling, Jon (2018) Antacid therapy for gastroesophageal reflux in preterm infants: a systematic review. BMJ Paediatrics Open, 2 (1). e00028/1-e00028/9. ISSN 2399-9772 Neonatology; Infant feeding https://bmjpaedsopen.bmj.com/content/2/1/e000287 doi:10.1136/bmjpo-2018-000287 doi:10.1136/bmjpo-2018-000287
spellingShingle Neonatology; Infant feeding
Dermyshi, Elda
Mackie, Charley
Kigozi, Phoebe
Schoonakker, Bernard
Dorling, Jon
Antacid therapy for gastroesophageal reflux in preterm infants: a systematic review
title Antacid therapy for gastroesophageal reflux in preterm infants: a systematic review
title_full Antacid therapy for gastroesophageal reflux in preterm infants: a systematic review
title_fullStr Antacid therapy for gastroesophageal reflux in preterm infants: a systematic review
title_full_unstemmed Antacid therapy for gastroesophageal reflux in preterm infants: a systematic review
title_short Antacid therapy for gastroesophageal reflux in preterm infants: a systematic review
title_sort antacid therapy for gastroesophageal reflux in preterm infants: a systematic review
topic Neonatology; Infant feeding
url https://eprints.nottingham.ac.uk/52333/
https://eprints.nottingham.ac.uk/52333/
https://eprints.nottingham.ac.uk/52333/